The present invention relates to pharmaceutical composition,comprising certain phosphate binder particles having a certainparticle size distribution, a process for the manufacture of thepharmaceuticalcomposition and the use of sucroferric oxyhydroxide having a certainparticle size distribution for the manufacture of a pharmaceuticalcomposition.